After announcing in March 2024 that she had been diagnosed with cancer, Kate Middleton, Princess of Wales, has again spoken out about her illness—this time, with good news. “It is a relief now to be ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SAN DIEGO -- ...

The study covered in this summary was published on ssrn.com as a preprint and has not yet been peer reviewed. Cytarabine plus an anthracycline has been the standard AML induction regimen for decades, ...

A new immunotherapy treatment for advanced melanoma had a reduction in disease progression in 50 percent of participants and complete remission in 20 percent, making it one of the most effective ...

Please provide your email address to receive an email when new articles are posted on . Treatment with CTX130, a novel chimeric antigen receptor T-cell therapy, led to disease control in more than ...

As soon as I entered complete remission for multiple myeloma, I felt a glimmer of hope. The word "remission" carries a sense of hope and relief, like the first ray of sunshine breaking through the ...

Many patients with late-stage blood cancers receiving an experimental T-cell therapy went into complete remission, according to preliminary research results from a Fred Hutchinson Cancer Research ...

Prior to initial therapy, tumor mass was defined in each patient as high or intermediate by standard criteria. High tumor mass required either Hb less than 8.5 g/dl or serum calcium greater than 11.5 ...

Hematologist-oncologist Leonard Klein had good news for his patient, a 65-year old woman with multiple myeloma. After chemotherapy and a stem-cell transplant, her disease was in complete remission.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Complete remission at 8 weeks was observed in patients ...

A groundbreaking gene therapy treatment which boosts a patient's own immune cells has been shown to clear disease from one third of terminal patients. US pharmaceutical company Kite Pharma released ...